| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 07/20/2005 | EP1436390A4 Retinoid inducible proteins of vascular smooth muscle cells and uses thereof |
| 07/20/2005 | EP1198570B1 Monomeric protein of the tgf-beta family |
| 07/20/2005 | EP1121137B1 Method for killing tumor and tumor associated endothelial cells using adenoviral mutants |
| 07/20/2005 | EP1005538B1 Potassium channel proteins for use in gene therapy for alleviating erectile dysfunction |
| 07/20/2005 | EP0979281B1 A method for making multispecific antibodies having heteromultimeric and common components |
| 07/20/2005 | EP0977878B1 Dna sequences coding for subunit chld of plant magnesium chelatases for determining their action |
| 07/20/2005 | EP0934407B1 Polycation-sensing receptor in aquatic species and methods of use thereof |
| 07/20/2005 | EP0929677B1 Recombinant method for preparing a complete malaria antigen gp190/msp1 |
| 07/20/2005 | EP0925362B1 Transgenic plants expressing cellulolytic enzymes |
| 07/20/2005 | EP0789761B1 Human scf, a splice variant thereof, its pharmaceutical use |
| 07/20/2005 | EP0721500B1 Insulin-secreting cell lines, methods of production and use |
| 07/20/2005 | EP0703983B9 Regulation of plant growth |
| 07/20/2005 | CN1643164A Recombinant bovine immunodeficiency virus based gene transfer system |
| 07/20/2005 | CN1643159A Method for generating primate trophoblasts |
| 07/20/2005 | CN1643152A Poison/antidote genetic systems for the selection of genetically modified eucaryote cells or organisms |
| 07/20/2005 | CN1643150A Gene participating in the synthesis of brassinosteroid |
| 07/20/2005 | CN1643149A Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor |
| 07/20/2005 | CN1643142A Method of identifying genes controlling diferentiation |
| 07/20/2005 | CN1643138A Novel cytokine ZCYTOR17 ligand |
| 07/20/2005 | CN1643137A Dedifferentiated, programmable stem cells of monocytic origin, and their production and use |
| 07/20/2005 | CN1643136A Method of proliferating human hepatocytes and method of obtaining human hepatocytes |
| 07/20/2005 | CN1643135A Isolated homozygous stem cells differentiated cells derived therefrom and materials and methods for making and using same |
| 07/20/2005 | CN1643134A Method for producing pseudo islets |
| 07/20/2005 | CN1643133A Chimeric pancreas |
| 07/20/2005 | CN1643132A Container with at least one electrode |
| 07/20/2005 | CN1642984A Specific Ab1'-antibodies against tumour-associated antigen CA 125 |
| 07/20/2005 | CN1642983A Antibodies against of C5aR and use thereof |
| 07/20/2005 | CN1642981A Antibody recognizing proliferative human liver cells proliferative human liver cells and functional human liver cells |
| 07/20/2005 | CN1642980A Antagonistic anti-hFAS ligand human antibodies and fragments thereof |
| 07/20/2005 | CN1642971A A nucleic acid encoding a G-protein-coupled receptor, and uses thereof |
| 07/20/2005 | CN1642567A HIV inhibiting proteins |
| 07/20/2005 | CN1642432A Method of improving food fermentation procedures |
| 07/20/2005 | CN1641019A Cephalosporin C acylases |
| 07/20/2005 | CN1641018A Method for producing non-human mammal chimeric embryo |
| 07/20/2005 | CN1641017A Microcarrier for large-scale culture cell |
| 07/20/2005 | CN1211488C Modified plant viruses as vectors of heterologous peptides |
| 07/20/2005 | CN1211487C Mutants of streptococcal toxin A and methods of use |
| 07/20/2005 | CN1211486C A DNA molecule encoding mutant prepro-neuropeptide Y, a mutant signal peptide, and uses thereof |
| 07/20/2005 | CN1211483C Polypeptides having branching enzyme activity and nucleic acids encoding same |
| 07/20/2005 | CN1211482C Method for activating human antigen presenting cells, activated human antigen presenting cells, and use of same |
| 07/20/2005 | CN1211126C Vascular endothelial growth factor 2 |
| 07/20/2005 | CN1211123C Humanized antibodies against leukocyte adhesion molecule VLA-4 |
| 07/19/2005 | US6919500 Transgenic seeds for propagation of disease, insect and herbicide resistant plants comprising modified phytic acid, fatty acid an/or carbohydrate metabolism |
| 07/19/2005 | US6919497 Producing a soybean plant produced by crossing the cultivar with itself or another soybean variety; hybrid soybean seeds and plants produced by crossing the cultivar and another cultivar |
| 07/19/2005 | US6919434 Monoclonal antibodies that bind OCIF |
| 07/19/2005 | US6919432 Substances and their uses |
| 07/19/2005 | US6919313 Amino acid sequences for use in the treatment of inflammation and autoimmune diseases |
| 07/19/2005 | US6919209 Using adeno-associated viral vector to stably transduce pluripotent progenitor cells with high efficiency; genetic engineering and heterologous gene expression; gene therapy |
| 07/19/2005 | US6919206 Medium containing flt3 ligand for culturing hematophoietic cells |
| 07/19/2005 | US6919195 Enzymatic polypeptide for use in food processing |
| 07/19/2005 | US6919187 Comprises polypeptides for use in serodiagnosis and treatment of chlamydial sexually transmitted disease; vaccines |
| 07/19/2005 | US6919186 Fluorescent proteins |
| 07/19/2005 | US6919183 Detecting and isolating cells that produce preferential protein; obtain cells, transfrom cells with vector containing preferential protein, detect protein on surface of cell, isolate cells displaying preferential protein |
| 07/19/2005 | US6919084 Antigen strain in vehicle; inducting immunology response |
| 07/14/2005 | WO2005063983A1 Modulators of bone homeostasis identified in a high-throughput screen |
| 07/14/2005 | WO2005063976A2 Methods for inducing differentiation of undifferentiated mammalian cells into osteoblasts |
| 07/14/2005 | WO2005063972A1 Embryonic stem cell line and method for preparing the same |
| 07/14/2005 | WO2005063971A2 Definitive endoderm |
| 07/14/2005 | WO2005063970A1 Methods for producing a549 cell lines stable in serum-free medium suspension culture |
| 07/14/2005 | WO2005063969A2 Methods for the identification and preparation of regulator/suppressor t lymphocytes, compositions and uses thereof |
| 07/14/2005 | WO2005063968A1 Basal medium for es cell culturing |
| 07/14/2005 | WO2005063967A1 Induction of myocardial cell with the use of mammalian bone marrow cell or cord blood-origin cell and fat tissue |
| 07/14/2005 | WO2005063966A2 Method for in vitro differentiation of neuronal stem cells or cells derived from neuronal stem cells |
| 07/14/2005 | WO2005063965A1 Tissue regeneration method |
| 07/14/2005 | WO2005063961A2 Electrofusion chamber and method for the quantification of hybridoma yields |
| 07/14/2005 | WO2005063820A2 Il-7 fusion proteins |
| 07/14/2005 | WO2005063816A2 Monovalent antibody fragments useful as therapeutics |
| 07/14/2005 | WO2005063813A2 Process for the production of tumor necrosis factor-binding proteins |
| 07/14/2005 | WO2005063801A2 Method for decreasing the contact between hepta-repeat region s of the corona-virus spike proteins and use thereof |
| 07/14/2005 | WO2005063316A1 Transplantable biomaterial and method of preparing the same |
| 07/14/2005 | WO2005063303A1 Use of human cord blood-derived pluripotent cells for the treatment of disease |
| 07/14/2005 | WO2005063280A1 Allogeneic tumor therapeutic agent |
| 07/14/2005 | WO2005062962A2 Methods and compositions for directing migration of neural progenitor cells |
| 07/14/2005 | WO2005062918A2 Methods of treating asthma |
| 07/14/2005 | WO2005062857A2 Creation of a biological atrioventricular bypass to compensate for atrioventricular block |
| 07/14/2005 | WO2005037144A3 Methods and compositions for growing corneal endothelial and related cells on biopolymers and creation of artifical corneal transplants |
| 07/14/2005 | WO2005032341A3 Methods of evaluating oocytes for storage or reproductive treatments |
| 07/14/2005 | WO2005026324A3 Method and composition for enhancing in vitro embryo development by supplementing culture medium with prostaglandin or a prostaglandin analog |
| 07/14/2005 | WO2005023990A3 Trans-splicing mediated photodynamic therapy |
| 07/14/2005 | WO2004101747A3 Identification and use of gpr54 and its ligands for reproductive disorders and contraception |
| 07/14/2005 | WO2004078927A3 Progenitor cells and methods of using same |
| 07/14/2005 | WO2004063024A3 Floral packaging material having prints thereon |
| 07/14/2005 | WO2003029424A3 Novel proteins and nucleic acids encoding same |
| 07/14/2005 | US20050155119 Chlorophyllous totipotent cell cultures |
| 07/14/2005 | US20050155115 Use of Nitric Oxide Modulators in Agrobacterium-mediated Plant Transformation |
| 07/14/2005 | US20050155112 Insecticidal protein for use as tool in preventing and controlling corn root worm infestation; biological pest control |
| 07/14/2005 | US20050155104 Toxin complex proteins and genes from Xenorhabus bovienii |
| 07/14/2005 | US20050155099 Propagating hepatitis c viral particles via culturing infected hepatocytes under reduced oxygen conditions; bioreactors |
| 07/14/2005 | US20050155094 Expression vector comprising nucleotide sequences coding human recombination activating protein (RAG-1) gene for use as tool in generating immunodeficient pigs; animal models and immunotherapy |
| 07/14/2005 | US20050155089 Transport protein for use in identifying modulators for prevention and treatment of inflammation, cardiovascular, neurological, reproductive and developmental disorders |
| 07/14/2005 | US20050154197 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 07/14/2005 | US20050154192 Anti-il13 receptor alpha1 neutralizing antibody |
| 07/14/2005 | US20050153941 Cell differntiation inhibiting agent, cell culture method using the same, culture medium, and cultured cell line |
| 07/14/2005 | US20050153917 Gene overexpression/underexpression; antibodies; drug screening; kits |
| 07/14/2005 | US20050153890 Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use |
| 07/14/2005 | US20050153886 nucleotide sequences comprising cDNA and genomic DNA that code for angiogenesis factors, used for gene therapy |
| 07/14/2005 | US20050153882 Polypeptides as angiogenesis inhibitors |
| 07/14/2005 | US20050153878 Fgfr agonists |
| 07/14/2005 | US20050153449 Method for producing insulin-secreting stem cells and cells derived therefrom |
| 07/14/2005 | US20050153447 Closed culture vessel comprising inlet and outlet filters for use in propagation of lymphocytes; bioreactors |